ClinVar Miner

Submissions for variant NM_004006.3(DMD):c.2168+13T>C

gnomAD frequency: 0.32216  dbSNP: rs228373
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000080482 SCV000112384 benign not specified 2017-04-24 criteria provided, single submitter clinical testing
GeneDx RCV000080482 SCV000168169 benign not specified 2013-11-22 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000080482 SCV000268950 benign not specified 2015-01-13 criteria provided, single submitter clinical testing c.2168+13T>C in intron 17 of DMD: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence. It has been identified in 47.4% (1816/3833) of African American chromosom es from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs. washington.edu/EVS; dbSNP rs228373).
PreventionGenetics, part of Exact Sciences RCV000080482 SCV000309925 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000320614 SCV000482271 benign Dilated cardiomyopathy 3B 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000080482 SCV000917281 benign not specified 2018-07-12 criteria provided, single submitter clinical testing Variant summary: DMD c.2168+13T>C alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. The variant allele was found at a frequency of 0.32 in 82561 control chromosomes in the ExAC database, including 3112 homozygotes. The observed variant frequency is approximately 28.65 fold of the estimated maximal expected allele frequency for a pathogenic variant in DMD causing Dystrophiopathies phenotype (0.011), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.2168+13T>C in individuals affected with Dystrophiopathies and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001811369 SCV001156887 benign not provided 2023-11-29 criteria provided, single submitter clinical testing
Invitae RCV001510188 SCV001717159 benign Duchenne muscular dystrophy 2024-02-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000320614 SCV001876803 benign Dilated cardiomyopathy 3B 2021-07-30 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001510188 SCV001876804 benign Duchenne muscular dystrophy 2021-07-30 criteria provided, single submitter clinical testing
Clinical Genetics, Academic Medical Center RCV000080482 SCV001920944 benign not specified no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000080482 SCV001962972 benign not specified no assertion criteria provided clinical testing
Natera, Inc. RCV001831834 SCV002092178 benign Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency 2017-08-09 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.